Why Is Johnson & Johnson (JNJ) Down 6.7% Since Last Earnings Report?
Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Benefits Pro1h
Johnson & Johnson sues federal government over legality of plan to offer 340B rebates
Johnson & Johnson on Tuesday sued the Biden administration in a controversy over how it distributes rebates under the federal ...
JNJ's Phase 2 Study Of Nipocalimab Shows Improvement In Disease Activity In Sjögren's Disease
(RTTNews) - Johnson & Johnson (JNJ), Thursday announced results from additional analyses of the Phase 2 DAHLIAS study, evaluating the effects of Nipocalimab in participants with primary Sjogren's ...
Taiwan News3h
Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study
Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...
Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day?
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
MassDevice19h
Johnson & Johnson MedTech inks distro deal to expand soft tissue solutions
Johnson & Johnson MedTech announced today that it entered into an exclusive commercial distribution agreement with Responsive Arthroscopy. The company agreed to a deal in the U.S. with Responsive ...
Opinion
The Slovak Spectator on MSN22hOpinion
“I feel fortunate to be a female in a lineage of strong Slovak women.”
Angela Meady lives in Thunder Bay, Ontario where many Slovak people settled from the 1880s through 1950s. Angela has degrees in English Literature, Philosophy and Information Science and is director ...